(Total Views: 312)
Posted On: 06/26/2020 10:10:46 AM
Post# of 47
$CTXR News Article - Citius Receives FDA Response on Pre-Investigational New Drug (PIND) Application for its Induced Mesenchymal Stem Cells (iMSCs) to Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19 https://marketwirenews.com/news-releases/citi...06440.html
(0)
(0)
My Twitter: WhyteStocks
